(Reuters) - AstraZeneca Plc expects its COVID-19 vaccine could receive U.S. Emergency Use Authorization at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the U.S. House of Representatives on Tuesday.
Ruud Dobber, executive vice president at AstraZeneca, said that the drugmaker expects to be able to deliver 50 million doses of the vaccine by the end of April.
Reporting by Michael Erman
Our Standards: The Thomson Reuters Trust Principles.